Chronic Obstructive Pulmonary Disease (Copd) Research

25 researchers across 5 institutions

25 Researchers
5 Institutions
1 Grant PIs
3 High Impact

Research in Chronic Obstructive Pulmonary Disease (COPD) investigates the underlying biological mechanisms, progression, and treatment of this progressive lung disease. Studies examine cellular and molecular pathways involved in airway inflammation and emphysema, as well as the development of novel therapeutic strategies. This includes research into genetic predispositions, environmental exposures, and the impact of co-existing conditions on disease severity and patient outcomes. Methodologies range from laboratory-based investigations using cell cultures and animal models to clinical studies involving patient data analysis and the evaluation of treatment efficacy.

Given Arkansas's demographic profile and prevalence of certain environmental factors, COPD research holds significant public health relevance for the state. Understanding the factors contributing to COPD in diverse populations within Arkansas is crucial for developing targeted public health interventions and improving healthcare delivery. This work can inform strategies to address health disparities and promote respiratory wellness across the state.

This area of study benefits from interdisciplinary collaboration, drawing upon expertise in health disparities and outcomes, pharmacology, and medical case studies. Engagement spans multiple institutions across Arkansas, fostering a broad network of researchers dedicated to advancing knowledge and improving the lives of individuals affected by COPD.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Michael Cho UAMS 28 3,204 High Impact
Mohammed S. Orloff UAMS 25 3,756 High Impact
Thaddeus Bartter UAMS 25 2,441 High Impact
Jonathan Williamson UAMS 22 1,758
Mayron F. Oliveira Lyon College 13 474
Amarnath Singh UAMS 12 777
Melissa Taylor University of Arkansas 10 257 Grants
Xuanyang Chen UA Little Rock 9 437
William T. Atchley UAMS 7 444
Anand N. Venkata UAMS 7 143
Krishna Kakkera UAMS 7 234
Maneetha Kodali UAMS 2 52
Jérémy Thomas UAMS 2 74
Elizabeth Eoff UAMS 1 1
J. Cheney UAMS 1 1
Madisyn L. Strain UAMS 1 7
P Ravikumar UAMS 1 4
Teja Krishna Kakkera UAMS 1 7
Rohan Seth UAMS 1 5
Maryam Alimohammadi University of Arkansas 0 0

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
10,474 works in 2026
-1.0% CAGR 2018–2026
Leadership concentration
4.8% held by global top 5 institutions
Fragmented HHI 18
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2026 window.

Top US institutions in this area

  1. 1 Harvard University 2,840
  2. 2 Brigham and Women's Hospital 2,763
  3. 3 University of Colorado Denver 2,553
  4. 4 Johns Hopkins University 2,244
  5. 5 National Jewish Health 1,794

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Chronic Obstructive Pulmonary Disease (Copd) Research.

Maryam Alimohammadi University of Arkansas
32%
30%
U Khan University of Arkansas – Fort Smith
Melissa Taylor University of Arkansas
29%
U Khan University of Arkansas – Fort Smith
29%
M Asif University of Arkansas – Fort Smith
Mayron F. Oliveira Lyon College
27%
25%
M Shahbaz University of Arkansas – Fort Smith
24%
M Shahbaz University of Arkansas – Fort Smith
19%
Maryam Alimohammadi University of Arkansas

Researchers with Federal Grants

Browse All 25 Researchers in Directory